实验室暴露在人类病原体和毒素的监测,加拿大,2021年
Emily R Thompson1, Maryem El Jaouhari1, Nadine Eltayeb1
1Health Security Regional Operations Branch, Public Health Agency of Canada, Ottawa, ON.
概括
2021年,加拿大实验室报告了43起暴露事件,人类互动和尖物是常见的原因. 与2020年相比,实验室事故的发生率略有下降,这表明安全措施有所改善.
科学领域:
- 公共卫生监督 公共卫生监督
- 实验室的安全工作.
- 传染病流行病学 传染病流行病学
背景情况:
- 加拿大实验室事故通报系统追踪"人类病原体和毒素法案"规定的事件.
- 本报告详细介绍了2021年加拿大的实验室暴露事件和受影响的个人.
研究的目的:
- 分析2021年加拿大的实验室暴露事件.
- 识别实验室事故中的趋势,根本原因和受影响人员.
- 为了比较2021年的事件率与前几年 (2016-2020) 的事件率.
主要方法:
- 从实验室事故通知加拿大系统提取的数据,用于2021年获得许可的加拿大实验室.
- 使用R软件进行描述性统计分析,根据部门,原因,活动和病原体类型检查事件率.
- 分析受影响个体的人口统计,暴露途径和角色,以及季节性分析.
主要成果:
- 报告了43起暴露事件,涉及72人,其中2例确诊,1例疑似实验室感染.
- 每年曝光事件率为每100个活跃许可证4.2,低于2020年的水平.
- 大多数事件涉及非安全敏感生物代理 (86.4%) 和风险组2病原体 (61.4%),其中细菌和病毒是最常见的. 微生物学活动和学术部门占主导地位. 与尖刀相关的事件 (22.2%) 和人类互动 (28.2%) 是最常见的根本原因. 吸入是主要的暴露途径 (52.8%).
- 峰值事件发生在9月和5月.
结论:
- 与2020年相比,2021年加拿大的实验室事故总量略有下降.
- 与尖刀相关的事件和人类互动问题 (例如,工作负载,人为错误) 分别是最常见的发生类型和根本原因.
- 了解这些趋势对于加强实验室安全协议和防止未来暴露至关重要.
关键词:
生物安全中心实验室事故通知 加拿大 加拿大人类病原体和毒素.实验室的暴露 实验室的暴露实验室事件 实验室事件在实验室获得的感染.监控监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督监督更多相关视频
09:54Safety Precautions and Operating Procedures in an ABSL-4 Laboratory: 1. Biosafety Level 4 Suit Laboratory Suite Entry and Exit Procedures
Published on: October 3, 2016
36.1K
10:17High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
9.7K
相关概念视频
Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Toxicity Testing in Animals
Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
Steps in Outbreak Investigation
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
Principles of Disease Surveillance
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
Investigation of Disease Outbreaks
Multistate foodborne outbreaks pose significant public health risks and require meticulous investigation to identify sources and implement control measures. The Centers for Disease Control and Prevention (CDC) utilizes a dynamic seven-step process for these investigations, integrating data from laboratories, interviews, and environmental assessments to protect public health.Outbreak Detection: The detection of multistate outbreaks typically begins with PulseNet, the CDC's national laboratory...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
